On May 6, 2025, West Pharmaceutical Services held its Annual Meeting where shareholders approved five key proposals, including the election of directors and amendments to Articles of Incorporation, with high participation (89.93% of shares represented). Notably, they ratified PricewaterhouseCoopers as their accounting firm for 2025 and adopted a right for shareholders to call special meetings.